AZD 0328
Alternative Names: AZD0328Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator AstraZeneca
- Class Antidementias; Quinuclidines
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Schizophrenia